Sigma's Talks With Boots Were Probably Valuable -- Market Talk

Dow Jones

Jun 15

0109 GMT - Sigma Healthcare's brief engagement with Boots likely yielded information valuable to its U.K. expansion plans, Citi analysts say. Having held preliminary talks over a potential acquisition of Boots, the Australian pharmacy chain operator probably has more detail on the U.K. market and its biggest player, they say. This is relevant since it recently announced plans to roll out its Chemist Warehouse brand in the U.K. The Citi analysts suggest Sigma also knows more about how investors would react to the purchase of a large incumbent player in a new market. They have an unchanged neutral rating on Sigma's stock and a target price of 3.20 Australian dollars. Shares are up 7.4% at A$2.835. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

June 14, 2026 21:09 ET (01:09 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2643846225"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2643846225\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2643846225?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 09:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2643846225","market":"fut","top_or_hot":-1,"title":"Sigma's Talks With Boots Were Probably Valuable -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0109 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a>'s brief engagement with Boots likely yielded information valuable to its U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. expansion plans, Citi analysts say. Having held preliminary talks over a potential acquisition of Boots, the Australian pharmacy chain operator probably has more detail on the U.K. market and its biggest player, they say. This is relevant since it recently announced plans to roll out its Chemist Warehouse brand in the U.K. The Citi analysts suggest Sigma also knows more about how investors would react to the purchase of a large incumbent player in a new market. They have an unchanged neutral rating on Sigma's stock and a target price of 3.20 Australian dollars. Shares are up 7.4% at A$2.835. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 14, 2026 21:09 ET (01:09 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sigma's Talks With Boots Were Probably Valuable -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSigma's Talks With Boots Were Probably Valuable -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-15 09:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0109 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a>'s brief engagement with Boots likely yielded information valuable to its U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. expansion plans, Citi analysts say. Having held preliminary talks over a potential acquisition of Boots, the Australian pharmacy chain operator probably has more detail on the U.K. market and its biggest player, they say. This is relevant since it recently announced plans to roll out its Chemist Warehouse brand in the U.K. The Citi analysts suggest Sigma also knows more about how investors would react to the purchase of a large incumbent player in a new market. They have an unchanged neutral rating on Sigma's stock and a target price of 3.20 Australian dollars. Shares are up 7.4% at A$2.835. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 14, 2026 21:09 ET (01:09 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7103","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2643846225","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2643846225","pubTimestamp":1781485740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0109 GMT - Sigma Healthcare's brief engagement with Boots likely yielded information valuable to its U.K. expansion plans, Citi analysts say. Having held preliminary talks over a potential acquisition of Boots, the Australian pharmacy chain operator probably has more detail on the U.K. market and its biggest player, they say. This is relevant since it recently announced plans to roll out its Chemist Warehouse brand in the U.K. The Citi analysts suggest Sigma also knows more about how investors would react to the purchase of a large incumbent player in a new market. They have an unchanged neutral rating on Sigma's stock and a target price of 3.20 Australian dollars. Shares are up 7.4% at A$2.835. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7103":"保健护理产品经销商","SIG.AU":"SIGMA HEALTHCARE LTD"},"translate_title":"Sigma与Boots的谈判可能很有价值——市场谈话","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIG.AU":0.9},"content_text":"0109 GMT - Sigma Healthcare's brief engagement with Boots likely yielded information valuable to its U.K. expansion plans, Citi analysts say. Having held preliminary talks over a potential acquisition of Boots, the Australian pharmacy chain operator probably has more detail on the U.K. market and its biggest player, they say. This is relevant since it recently announced plans to roll out its Chemist Warehouse brand in the U.K. The Citi analysts suggest Sigma also knows more about how investors would react to the purchase of a large incumbent player in a new market. They have an unchanged neutral rating on Sigma's stock and a target price of 3.20 Australian dollars. Shares are up 7.4% at A$2.835. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 14, 2026 21:09 ET (01:09 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}